To achieve this, we provide an overview of the hypothesised pathways and mechanisms illustrating how ApoE ε4, secreted either in the brain or peripheral tissues, might impact BBB integrity and, thus, affect AD pathogenesis. Here, APOE is linked to Alzheimer disease.